Imaflex Inc.

TSXV:IFX Stock Report

Market Cap: CA$62.5m

Imaflex Balance Sheet Health

Financial Health criteria checks 6/6

Imaflex has a total shareholder equity of CA$63.8M and total debt of CA$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CA$89.4M and CA$25.6M respectively. Imaflex's EBIT is CA$5.5M making its interest coverage ratio 9.7. It has cash and short-term investments of CA$10.8M.

Key information

0%

Debt to equity ratio

CA$0

Debt

Interest coverage ratio9.7x
CashCA$10.77m
EquityCA$63.81m
Total liabilitiesCA$25.56m
Total assetsCA$89.38m

Recent financial health updates

Is Imaflex (CVE:IFX) A Risky Investment?

Nov 25
Is Imaflex (CVE:IFX) A Risky Investment?

We Think Imaflex (CVE:IFX) Can Stay On Top Of Its Debt

Mar 14
We Think Imaflex (CVE:IFX) Can Stay On Top Of Its Debt

Does Imaflex (CVE:IFX) Have A Healthy Balance Sheet?

Aug 24
Does Imaflex (CVE:IFX) Have A Healthy Balance Sheet?

Imaflex (CVE:IFX) Could Easily Take On More Debt

Oct 23
Imaflex (CVE:IFX) Could Easily Take On More Debt

Imaflex (CVE:IFX) Seems To Use Debt Rather Sparingly

Jun 03
Imaflex (CVE:IFX) Seems To Use Debt Rather Sparingly

Is Imaflex (CVE:IFX) A Risky Investment?

Jan 17
Is Imaflex (CVE:IFX) A Risky Investment?

Recent updates

Imaflex (CVE:IFX) Is Reinvesting At Lower Rates Of Return

Aug 29
Imaflex (CVE:IFX) Is Reinvesting At Lower Rates Of Return

Market Might Still Lack Some Conviction On Imaflex Inc. (CVE:IFX) Even After 28% Share Price Boost

Aug 29
Market Might Still Lack Some Conviction On Imaflex Inc. (CVE:IFX) Even After 28% Share Price Boost

Revenues Not Telling The Story For Imaflex Inc. (CVE:IFX) After Shares Rise 48%

Jun 13
Revenues Not Telling The Story For Imaflex Inc. (CVE:IFX) After Shares Rise 48%

There May Be Some Bright Spots In Imaflex's (CVE:IFX) Earnings

Jun 05
There May Be Some Bright Spots In Imaflex's (CVE:IFX) Earnings

Imaflex (CVE:IFX) Might Be Having Difficulty Using Its Capital Effectively

Jan 06
Imaflex (CVE:IFX) Might Be Having Difficulty Using Its Capital Effectively

Is Imaflex (CVE:IFX) A Risky Investment?

Nov 25
Is Imaflex (CVE:IFX) A Risky Investment?

Does Imaflex (CVE:IFX) Deserve A Spot On Your Watchlist?

May 25
Does Imaflex (CVE:IFX) Deserve A Spot On Your Watchlist?

We Think Imaflex (CVE:IFX) Can Stay On Top Of Its Debt

Mar 14
We Think Imaflex (CVE:IFX) Can Stay On Top Of Its Debt

Does Imaflex (CVE:IFX) Have A Healthy Balance Sheet?

Aug 24
Does Imaflex (CVE:IFX) Have A Healthy Balance Sheet?

Is It Too Late To Consider Buying Imaflex Inc. (CVE:IFX)?

May 10
Is It Too Late To Consider Buying Imaflex Inc. (CVE:IFX)?

Imaflex (CVE:IFX) Could Easily Take On More Debt

Oct 23
Imaflex (CVE:IFX) Could Easily Take On More Debt

Investors Should Be Encouraged By Imaflex's (CVE:IFX) Returns On Capital

Sep 04
Investors Should Be Encouraged By Imaflex's (CVE:IFX) Returns On Capital

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Imaflex Inc.'s (CVE:IFX) CEO For Now

Jun 10
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Imaflex Inc.'s (CVE:IFX) CEO For Now

Imaflex (CVE:IFX) Seems To Use Debt Rather Sparingly

Jun 03
Imaflex (CVE:IFX) Seems To Use Debt Rather Sparingly

Here's Why I Think Imaflex (CVE:IFX) Might Deserve Your Attention Today

Apr 19
Here's Why I Think Imaflex (CVE:IFX) Might Deserve Your Attention Today

Imaflex (CVE:IFX) Shareholders Will Want The ROCE Trajectory To Continue

Mar 30
Imaflex (CVE:IFX) Shareholders Will Want The ROCE Trajectory To Continue

Did Imaflex Inc. (CVE:IFX) Insiders Sell Shares?

Mar 01
Did Imaflex Inc. (CVE:IFX) Insiders Sell Shares?

Is Imaflex Inc.'s (CVE:IFX) Latest Stock Performance A Reflection Of Its Financial Health?

Feb 04
Is Imaflex Inc.'s (CVE:IFX) Latest Stock Performance A Reflection Of Its Financial Health?

Is Imaflex (CVE:IFX) A Risky Investment?

Jan 17
Is Imaflex (CVE:IFX) A Risky Investment?

What We Make Of Imaflex's (CVE:IFX) Returns On Capital

Dec 30
What We Make Of Imaflex's (CVE:IFX) Returns On Capital

Imaflex (CVE:IFX) Is Growing Earnings But Are They A Good Guide?

Dec 15
Imaflex (CVE:IFX) Is Growing Earnings But Are They A Good Guide?

Have Insiders Sold Imaflex Inc. (CVE:IFX) Shares Recently?

Nov 30
Have Insiders Sold Imaflex Inc. (CVE:IFX) Shares Recently?

What Does Imaflex's (CVE:IFX) CEO Pay Reveal?

Nov 26
What Does Imaflex's (CVE:IFX) CEO Pay Reveal?

Financial Position Analysis

Short Term Liabilities: IFX's short term assets (CA$40.1M) exceed its short term liabilities (CA$16.0M).

Long Term Liabilities: IFX's short term assets (CA$40.1M) exceed its long term liabilities (CA$9.6M).

Debt to Equity History and Analysis

Debt Level: IFX is debt free.

Reducing Debt: IFX has no debt compared to 5 years ago when its debt to equity ratio was 26.7%.

Debt Coverage: IFX has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: IFX has no debt, therefore coverage of interest payments is not a concern.

Balance Sheet

Discover healthy companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/27 14:03
End of Day Share Price 2025/10/23 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Imaflex Inc. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Donangelo VolpeBeacon Securities Limited